193 related articles for article (PubMed ID: 32647928)
1. Efficacy and safety of adrenergic beta-antagonist combined with lasers in the treatment of infantile hemangiomas: a meta-analysis.
Chen X; Guo Y; Wang P; Qiu F; Sun Y; Shi Q; Deng Y; Hu C; Lei S
Pediatr Surg Int; 2020 Oct; 36(10):1135-1147. PubMed ID: 32647928
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies.
Huang H; Chen X; Cai B; Yu J; Wang B
Dermatol Ther; 2022 Dec; 35(12):e15907. PubMed ID: 36205218
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies.
Lin Z; Zhang B; Yu Z; Li H
Br J Clin Pharmacol; 2020 Feb; 86(2):199-209. PubMed ID: 31833573
[TBL] [Abstract][Full Text] [Related]
4. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials.
Wang X; Feng W; Zhao X; Liu Z; Dong L
Dermatology; 2021; 237(3):433-443. PubMed ID: 33027794
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma.
Fernández Faith E; Shah S; Witman PM; Harfmann K; Bradley F; Blei F; Pope E; Alsumait A; Gupta D; Covelli I; Streicher JL; Cotton C; Tollefson M; Nguyen H; Hunt R; Moore-Clingenpeel M; Frieden IJ
JAMA Dermatol; 2021 May; 157(5):566-572. PubMed ID: 33787840
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Combined Topical Timolol and Oral Propranolol for Treating Infantile Hemangioma: A Meta-Analysis of Randomized Controlled Trials.
Qiao J; Lin J; Zhang D; Li J; Chen C; Yu H; Li X; Fang B
Front Pharmacol; 2020; 11():554847. PubMed ID: 33132908
[TBL] [Abstract][Full Text] [Related]
8. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
[TBL] [Abstract][Full Text] [Related]
9. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
10. Topical timolol maleate 0.5% for infantile hemangioma; it's effectiveness and/or adjunctive pulsed dye laser - single center experience of 102 cases in Korea.
Park KH; Jang YH; Chung HY; Lee WJ; Kim DW; Lee SJ
J Dermatolog Treat; 2015; 26(4):389-91. PubMed ID: 25424048
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.
Liu X; Qu X; Zheng J; Zhang L
PLoS One; 2015; 10(9):e0138100. PubMed ID: 26375455
[TBL] [Abstract][Full Text] [Related]
12. Infantile hemangiomas, complications and treatments.
Cheng CE; Friedlander SF
Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318
[TBL] [Abstract][Full Text] [Related]
13. Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis.
Zheng L; Li Y
Arch Dermatol Res; 2018 May; 310(4):261-269. PubMed ID: 29362868
[TBL] [Abstract][Full Text] [Related]
14. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O
Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885
[TBL] [Abstract][Full Text] [Related]
16. Infantile Hemangioma: An Updated Review.
Leung AKC; Lam JM; Leong KF; Hon KL
Curr Pediatr Rev; 2021; 17(1):55-69. PubMed ID: 32384034
[TBL] [Abstract][Full Text] [Related]
17. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of treatments for infantile hemangiomas: a Bayesian network meta-analysis.
Yang H; Hu DL; Xuan XX; Chen JJ; Xu S; Wu XJ; Zhang H; Shu Q; Guo XD
Int J Dermatol; 2020 Nov; 59(11):1320-1331. PubMed ID: 32662887
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Infantile Hemangiomas in the Neonate.
Harter N; Mancini AJ
Pediatr Clin North Am; 2019 Apr; 66(2):437-459. PubMed ID: 30819347
[TBL] [Abstract][Full Text] [Related]
20. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
Tawfik AA; Alsharnoubi J
Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
